<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Nosology and Classification of Genetic Skeletal Disorders: 2010 Revision</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2011-03-15">15 March 2011</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Matthew</forename><forename type="middle">L</forename><surname>Warman</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Orthopaedic Surgery</orgName>
								<orgName type="laboratory">Orthopaedic Research Laboratories</orgName>
								<orgName type="institution" key="instit1">The Howard Hughes Medical Institute</orgName>
								<orgName type="institution" key="instit2">Children&apos;s Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Valerie</forename><surname>Cormier-Daire</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Genetics and INSERM U781</orgName>
								<orgName type="institution">Paris Descartes University</orgName>
								<address>
									<settlement>Hôpital</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Necker Enfants Malades</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Hall</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Child Health</orgName>
								<orgName type="institution">University of London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Deborah</forename><surname>Krakow</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Medical Genetics Institute</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<address>
									<addrLine>Steven Spielberg Building</addrLine>
									<settlement>Los Angeles</settlement>
									<region>California</region>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Departments of Orthopaedic Surgery and Human Genetics</orgName>
								<orgName type="institution">UCLA</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralph</forename><surname>Lachman</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Medical Genetics Institute</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<address>
									<addrLine>Steven Spielberg Building</addrLine>
									<settlement>Los Angeles</settlement>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martine</forename><surname>Lemerrer</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Genetics and INSERM U781</orgName>
								<orgName type="institution">Paris Descartes University</orgName>
								<address>
									<settlement>Hôpital</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Necker Enfants Malades</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Geert</forename><surname>Mortier</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Medical Genetics</orgName>
								<orgName type="institution" key="instit1">University Hospital of Antwerp</orgName>
								<orgName type="institution" key="instit2">University of Antwerp</orgName>
								<address>
									<settlement>Edegem</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><surname>Mundlos</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institut f€ ur Medizinische Genetik</orgName>
								<address>
									<settlement>Charit</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gen</forename><surname>Nishimura</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Pediatric Imaging</orgName>
								<orgName type="institution">Tokyo Metropolitan Children&apos;s Medical Center</orgName>
								<address>
									<settlement>Fuchu, Tokyo</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">L</forename><surname>Rimoin</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Medical Genetics Institute</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<address>
									<addrLine>Steven Spielberg Building</addrLine>
									<settlement>Los Angeles</settlement>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephen</forename><surname>Robertson</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Paediatrics and Child Health</orgName>
								<orgName type="department" key="dep2">Dunedin School of Medicine</orgName>
								<orgName type="institution">Otago University</orgName>
								<address>
									<settlement>Dunedin</settlement>
									<country key="NZ">New Zealand</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ravi</forename><surname>Savarirayan</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution" key="instit1">Murdoch Children&apos;s Research Institute</orgName>
								<orgName type="institution" key="instit2">Royal Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit3">University of Melbourne</orgName>
								<address>
									<settlement>Victoria</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Sillence</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Discipline of Genetic Medicine</orgName>
								<orgName type="department" key="dep2">The Children&apos;s Hospital at Westmead Clinical School</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Juergen</forename><surname>Spranger</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Centre for Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution" key="instit1">Freiburg University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sheila</forename><surname>Unger</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Centre for Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution" key="instit1">Freiburg University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff14">
								<orgName type="department">Medical Genetics Service</orgName>
								<orgName type="institution" key="instit1">University of Lausanne</orgName>
								<orgName type="institution" key="instit2">CHUV-Centre Hospitalier Universitaire Vaudois</orgName>
								<address>
									<settlement>Lausanne</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernhard</forename><surname>Zabel</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Centre for Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution" key="instit1">Freiburg University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Superti-Furga</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Centre for Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution" key="instit1">Freiburg University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution" key="instit1">University of Lausanne</orgName>
								<orgName type="institution" key="instit2">CHUV-Centre Hospitalier Universitaire Vaudois</orgName>
								<address>
									<settlement>Lausanne</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Warman</forename><surname>Ml</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rimoin</forename><surname>Dl</surname></persName>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="institution" key="instit1">Universit€ atsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Max-Planck-Institut f€ ur Molekulare Genetik</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="institution">Children&apos;s Hospital</orgName>
								<address>
									<settlement>Research, Boston</settlement>
									<region>Massachusetts</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="institution">Children&apos;s Orthopaedic Surgery Foundation, Inc</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">Enobia Pharma</orgName>
								<orgName type="institution">The Osteogenesis Imperfecta Foundation</orgName>
								<address>
									<settlement>Gaithersburg, Biomarin, Novato, Montreal</settlement>
									<region>Maryland, California, Quebec</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="laboratory">Centre Hospitalier Universitaire Vaudois (CHUV)</orgName>
								<address>
									<addrLine>Av. Decker, 2</addrLine>
									<postCode>1011</postCode>
									<settlement>Lausanne</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Nosology and Classification of Genetic Skeletal Disorders: 2010 Revision</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2011-03-15">15 March 2011</date>
						</imprint>
					</monogr>
					<idno type="MD5">9F6D84227EBFA030261B4647E0CBB97B</idno>
					<idno type="DOI">10.1002/ajmg.a.33909</idno>
					<note type="submission">Received 16 December 2010; Accepted 30 December 2010 The 9th ISDS meeting and the Nosology workshop were held in Boston in July 2009 and supported by The Manton Center for Orphan Disease</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>skeletal genetics</term>
					<term>osteochondrodysplasias</term>
					<term>nosology</term>
					<term>dysostoses</term>
					<term>molecular basis of disease</term>
				</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Genetic disorders involving the skeletal system arise through disturbances in the complex processes of skeletal development, growth and homeostasis and remain a diagnostic challenge because of their variety.</s><s>The Nosology and Classification of Genetic Skeletal Disorders provides an overview of recognized diagnostic entities and groups them by clinical and radiographic features and molecular pathogenesis.</s><s>The aim is to provide the Genetics, Pediatrics and Radiology community with a list of recognized genetic skeletal disorders that can be of help in the diagnosis of individual cases, in the delineation of novel disorders, and in building bridges between clinicians and scientists interested in skeletal biology.</s><s>In the 2010 revision, 456 conditions were included and placed in 40 groups defined by molecular, biochemical, and/or radiographic criteria.</s><s>Of these conditions, 316 were associated with mutations in one or more of 226 different genes, ranging from common, recurrent mutations to ''private'' found in single families or individuals.</s><s>Thus, the Nosology is a hybrid between a list of clinically defined disorders, waiting for molecular clarification, and an annotated database documenting the phenotypic spectrum produced by mutations in a given gene.</s><s>The Nosology should be useful for the diagnosis of patients with genetic skeletal diseases, particularly in view of the information flood expected with the novel sequencing technologies; in the delineation of clinical entities and novel disorders, by providing an overview of established nosologic entities; and for scientists looking for the clinical correlates of genes, proteins and pathways involved in skeletal biology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>In the 1960s, accumulating evidence that genetic skeletal disorders were clinically and genetically heterogeneous prompted a group of international experts to prepare a document to reach an agreement on the nomenclature of what was then called ''constitutional (or intrinsic) disorders of bone' <ref type="bibr" target="#b0">' [1970</ref><ref type="bibr">, 1971a,b,c,d;</ref><ref type="bibr" target="#b11">McKusick and Scott, 1971</ref>].</s><s>The ''Nomenclature'' was meant to bring together experts in radiology, clinical genetics, and pediatrics to agree on the denomination and classification of skeletal disorders, syndromes and metabolic diseases that were being newly described.</s><s>Revisions have been prepared <ref type="bibr" target="#b5">in 1977</ref><ref type="bibr" target="#b7">in , 1983</ref><ref type="bibr" target="#b18">in , 1992</ref><ref type="bibr">in , and 1997</ref><ref type="bibr">in [1978</ref><ref type="bibr" target="#b13">in , 1979</ref><ref type="bibr" target="#b7">in , 1983</ref><ref type="bibr" target="#b10">in , 1998</ref><ref type="bibr" target="#b13">in , Rimoin, 1979;;</ref><ref type="bibr" target="#b18">Spranger, 1992;</ref><ref type="bibr" target="#b10">Lachman, 1998]</ref>.</s><s>Following the establishment of the International Skeletal Dysplasia Society (ISDS) in 1999, and to cope with the increasing complexity of information, revisions of the Nosology have been delegated to an expert group nominated ad hoc within the ISDS to ensure an adequate representation of clinical, radiological and molecular expertise <ref type="bibr">(2001 and 2006 revisions)</ref>  <ref type="bibr" target="#b9">[Hall, 2002;</ref><ref type="bibr" target="#b20">Superti-Furga and Unger, 2007]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head><p><s>The Nosology Group of the International Skeletal Dysplasia Society met in August 2009.</s><s>A consensus was reached for changes to be made to the grouping of disorders and about the inclusion of individual disorders.</s><s>The drafts were circulated after the meeting and an effort was made to monitor recent publications up to November 2010.</s><s>The criteria used for inclusion of individual disorders were unchanged from the previous revision.</s><s>They were:</s></p><p><s>(1) Significant skeletal involvement, corresponding to the definition of skeletal dysplasias, metabolic bone disorders, dysostoses, and skeletal malformation and/or reduction syndromes.</s><s>(2) Publication and/or listing in MIM (meaning that observations should not find their way into the Nosology before they achieve peer-reviewed publication status).</s></p><p><s>(3) Genetic basis proven by pedigree or very likely based on homogeneity of phenotype in unrelated families.</s><s>(4) Nosologic autonomy confirmed by molecular or linkage analysis and/or by the presence of distinctive diagnostic features and of observation in multiple individuals or families.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Four hundred fifty-six different conditions were included and placed in 40 groups defined by molecular, biochemical and/or radiographic criteria.</s><s>Of these conditions, 316 (2006 revision: 215) were associated with one or more of 226 (2006 revision: 140) different genes.</s><s>The results are presented in Table <ref type="table" target="#tab_0">I</ref>.</s><s>Within a group, disorders with known molecular basis have been listed preceding those with lesser degree of evidence; however, variants of the same disorder have been kept together.</s></p><p><s>The organization of groups has been further changed in comparison to the 2006 version.</s><s>Two new groups based on a common affected molecule or biochemical pathway have been created (TRPV4 group and Aggrecan group).</s><s>The TRPV4 group includes disorders that are relatively common and that constitute a new prototypic spectrum ranging from mild to lethal.</s><s>Aggrecan is one of the important structural molecules in cartilage and it would not be surprising if more disorders would find their way into this group in the future.</s><s>Thus, groups 1-8 are based on a common underlying gene or pathway.</s></p><p><s>Groups 9-17 are based on the localization of radiographic changes to specific bone structures (vertebrae, epiphyses, metaphyses, diaphysis, or combination thereof) or of the involved segment (rhizo, meso, or acro).</s><s>Groups 18-20 are defined by macroscopic criteria in combination with clinical features (bent bones, slender bones, presence of multiple dislocations).</s><s>Groups 21-25 and 28 take into account features of mineralization (increased or reduced bone density, impaired mineralization, stippling, osteolysis).</s><s>Group 27 encompasses the large group of lysosomal disorders with skeletal involvement.</s><s>Group 29 comprises disorders with so-called abnormal (previously ''anarchic'') development of skeletal components such as exostoses, ecnhondromas, and ectopic calcification.</s><s>It is particularly heterogeneous and may need to be revised in the future with the help of newer molecular data.</s></p><p><s>Group 23, comprising the osteopetrosis (OP) variants and related disorders, has been expanded following the identification of distinct genetic defects in various variants of osteopetrosis.</s><s>The diversity of molecular mechanisms involved and the presence of clinical, biochemical and/or histologic features that distinguish between the various OP forms justify the subdivision of the ''OP phenotype'' in the many subtypes.</s></p><p><s>Group 25 (Osteogenesis Imperfecta and decreased bone density group) has had special attention.</s><s>The Sillence classification, published 30 years ago, provided a first systematic clinical classification and made correlations to the inheritance pattern of individual clinical types <ref type="bibr" target="#b15">[Sillence and Rimoin, 1978;</ref><ref type="bibr">Sillence et al., 1979a,b]</ref>.</s><s>Today, a surprising genetic complexity of the molecular bases of OI has been revealed, and at the same time the extensive phenotypic variation arising from single loci has been documented clearly.</s><s>It seemed therefore untenable to try and maintain tight correlations between ''Sillence types'' and their molecular basis.</s><s>It was agreed upon to retain the Sillence classification as the prototypic and universally accepted way to classify the degree of severity in OI; and to free the Sillence classification from any direct molecular reference.</s><s>Thus, the many genes that may cause osteogenesis imperfecta have been listed separately.</s><s>The proliferation of ''OI types'' to reflect            See also Spondylo-Carpal-Tarsal dysplasia; mesomelic dysplasia with acral synostoses; and others In Group 29 (Disorganized Development of Skeletal Components), neurofibromatosis type 1 has been included following the points made by Stevenson and others that although the main clinical features of NF1 are neurologic and cutaneous, the skeletal features are frequent, diagnostically helpful and clinically relevant <ref type="bibr" target="#b19">[Stevenson et al., 2007]</ref>.</s></p><p><s>Groups 30 (Overgrowth syndromes with significant skeletal involvement) and Group 31 (Genetic inflammatory/rheumatoidlike osteoarthropathies) have been newly added.</s><s>Group 30 comprises disorders that present as overgrowth syndromes and have a significant skeletal component that is part of the diagnostic criteria for a specific condition.</s><s>One condition has been tentatively included because of its conspicuous skeletal features <ref type="bibr" target="#b12">[Nishimura et al., 2004;</ref><ref type="bibr" target="#b14">Schmidt et al., 2007]</ref>; however this condition remains incompletely delineated.</s><s>Group 31 includes disorders with features of inflammation and skeletal involvement.</s><s>The creation of these two groups has been suggested by the frequent diagnostic overlap between these disorders and primary skeletal disorders as well as by the identification of the genetic basis of such disorders in recent years, allowing for a more precise delineation of the phenotypes.</s></p><p><s>Finally, groups 32-40 are dedicated to the dysostoses and follow again anatomical criteria (cranium, face, axial skeleton, extremities) with additional criteria reflecting principles of embryonic development such as limb reduction or hypoplasia (proximaldistal growth) versus terminal differentiation and patterning of the digits or joint formation.</s><s>These groups have seen a marked increase in conditions with identified molecular bases and there are indications of a much larger heterogeneity yet.</s></p><p><s>A single group, the Brachyolmias (formerly group 13), has been deleted.</s><s>Following the inclusion of dominant brachyolmia in the TRPV4 group, the few remaining short-trunk disorders have been incorporated in the SED group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION Why ''Groups''?</head><p><s>The assignment of individual disorders into groups has been practiced since the first versions of the ''Nomenclature.''</s><s>At that time, with little biochemical or molecular information available, the grouping of disorders reflected the belief that disorders with similar phenotypic features (e.g., dysostosis multiplex) might be caused by disturbances in related metabolic pathways or gene networks (in the case of dysostosis multiplex, lysosomal degradation).</s><s>This notion has been confirmed by the identification of biochemically related groups, such as those of mineralization disorders or lysosomal disorders, and of genetic families such as the collagen 2 family, the FGFR3 family, and the DTDST family.</s><s>The grouping of disorders is necessary because of the sheer number of conditions included, and can be helpful in making a differential diagnosis based on the main phenotypic findings, for example, in the mesomelic dysplasias or in chondrodysplasia punctata.</s><s>Some groups are still defined by common radiographic features or by anatomical site involved.</s><s>More-over, the nosology committee recognizes that some readers may disagree with our placement of a clinical entity into one group, when it may fit equally well in another group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Which Classification Criteria to Use?</head><p><s>Criticism to the previous versions of the Nosology has focused on its ''hybrid'' nature, in the sense that it does not stick to a single systematic approach, be it clinical or molecular.</s><s>This hybrid nature is intrinsic to the process of unraveling the underlying bases of skeletal diseases; disorders are classified on phenotypic similarities first, and as their molecular bases become understood they may be reclassified based on the gene or pathway that is abnormal.</s><s>The first aim of the Nosology is to provide a reference list, and only secondarily to help in the diagnostic process.</s><s>It must therefore coexist with other classifications that are based either on the clinical and radiographic approach to diagnosis, or the affected molecular systems and pathways.</s><s>As more and more resources are published on the World Wide Web, crosslinking between classifications and databases may facilitate their simultaneous use.</s></p><p><s>Although care has been given to apply the inclusion criteria uniformly, there are disorders without proven molecular or biochemical defect for which inclusion in the Nosology as distinct entities seem somewhat arbitrary.</s><s>For these disorders, discussion within the Nosology group, where individual opinions can be harmonized and, if needed, corrected by the collective expertise, is of great importance.</s><s>Moreover, there are disorders listed in MIM that have not met our inclusion criteria, in most instances because of too few observations or because of the lack of features allowing clear diagnostic distinction from other disorders.</s><s>It is likely that additional observations or the demonstration of a distinct molecular basis will allow for the inclusion of many of these disorders in the future, either as separate entities or as ''variants'' of already existing ones.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dysplasias Versus Dysostoses</head><p><s>Dysostoses are disorders affecting individual bones or group of bones.</s><s>In contrast to the ''dysplasias,'' that arise frequently from defects in structural proteins, metabolic processes or in growth plate regulation, the dysostoses often arise from embryonic morphogenic defects and are thus more closely related to multiple malformation syndromes.</s><s>Since the first inclusion of dysostoses in the 2001 revision, the number of ''dysostoses'' included in the Nosology has grown significantly.</s><s>The present revision includes an even larger number of dysostoses reflecting the advances made in identifying their molecular basis.</s><s>The boundaries between skeletal dysplasias and dysostoses, metabolic and molecular disorders, and multiple congenital anomalies syndromes is becoming progressively less sharp, and the diagnostic process requires knowledge that crosses between these subspecialty areas; the group of (cranio-)frontonasal disorders and the Franck-ter Haar syndrome can be cited as examples.</s><s>The MIM catalogue contains many more entries, such as multiple malformation syndromes, that have some degree of skeletal involvement.</s><s>Emphasis has been given to syndromes in which the skeletal component is prominent and/or essential to the diagnosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OMIM and the Nosology</head><p><s>Because of the importance of consistency between parallel databases, the relationship between the Nosology and the OMIM database has been reviewed.</s><s>The more comprehensive nature of the data collection and filing in MIM and the different nature of its revision process can lead to a divergence between the inclusion of nosologic entities and their denomination.</s><s>Thus, MIM is in general more appositional, while the Nosology tries to do some ''housekeeping'' of entities by regrouping them and by eliminating those that have been incorporated into others.</s><s>Efforts to made to harmonize the MIM and the Nosology are underway.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outlook</head><p><s>The increasing availability of massive parallel sequencing and other new sequencing technologies will likely result in a rapid identification of novel disease-causing genes, but also in novel phenotypes associated with mutations in genes already linked to other phenotypes.</s><s>In the near future, the catalog of skeletal phenotypes with a genetic basis may become so large as to surpass the scope of a ''Nosology'' as we understand it presently, and the Nosology will transform into an annotated database.</s></p><p><s>Even in that case, the many revisions of the Nosology will hopefully have paved the way by setting standards for the recognition and definition of skeletal phenotypes.</s><s>Past versions of the Nosology have been translated in different languages and have found their way into textbooks of pediatrics and genetics.</s><s>At present, the Nosology may help the clinician who is struggling for a diagnosis, by providing a simple listing of disorders grouped by cardinal features.</s><s>The Nosology offers a quick reminder of the many differential diagnoses for one given disorder.</s><s>As an expert-reviewed list of currently recognized disorders, the Nosology also constitutes a standard against which a possible ''new'' disorder should be compared.</s><s>Finally, the Nosology offers a catalogue of genes involved in skeletal development and homeostasis that will be of interest and of inspiration to all those who are working in skeletal biology and medicine.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>imperfecta and decreased bone density group For comments the classification of osteogenesis imperfecta, please refer to the text Osteogenesis imperfecta, non-deforming form (OI type 1</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>See also Pycnodysostosis, cleidocranial dysplasia, and Singleton-Merten syndrome.</s><s>Note: several neurologic conditions may cause acroosteolysis 29.</s><s>Disorganized development of skeletal components group Multiple cartilaginous</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FGFR3</head><label></label><figDesc><div><p><s>-Carpenter syndrome in group 24, CDAGS syndrome in group 29, and Craniofrontonasal syndrome in group 34 34.</s><s>Dysostoses with predominant craniofacial involvement Mandibulo-facial-digital syndrome type IV in the Short Rib Dysplasias group 35.</s><s>Dysostoses with predominant vertebral with and without costal involvement Currarino dysplasia in group 7 and spondylo-metaphyseal-megaepiphyseal dysplasia in group 13 36group for conditions with patellar changes as well as ischio-pubic-patellar dysplasia as mild expression of campomelic dysplasia 37. Brachydactylies (with or without extraskeletal manifestations) 20 for other conditions with brachydactyly as well as brachytelephalangic CDP 38.</s><s>Limb hypoplasia-reduction defects group Ulnarparticularly complex genetic basis of Fanconi anemia and its complementation groups are acknowledged but not further listed in this Nosology.</s><s>The Reader is referred to MIM or to specialized reviews.</s><s>See also CHILD in group 20 and the mesomelic and acromesomelic dysplasias 39.</s><s>Polydactyly-Syndactyly-Triphalangism group Preaxial polydactyly type 1 Smith-Lemli-Opitz syndrome can present with polydactyly and/or syndactyly.</s><s>See also the SRPS group 40.</s><s>Defects in joint formation and synostoses Multiple synostoses</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE I .</head><label>I</label><figDesc></figDesc><table><row><cell>Group/name of disorder Inheritance MIM No. Locus Gene Protein Notes</cell><cell>1. FGFR3 chondrodysplasia group</cell><cell>Thanatophoric dysplasia type 1 (TD1) AD 187600 4p16.3 FGFR3 FGFR3 Includes previous San</cell><cell>Diego type</cell><cell>Thanatophoric dysplasia type 2 (TD2) AD 187601 4p16.3 FGFR3 FGFR3</cell><cell>Severe achondroplasia with AD See 4p16.3 FGFR3 FGFR3</cell><cell>developmental delay and acanthosis 187600</cell><cell>nigricans (SADDAN)</cell><cell>Achondroplasia AD 100800 4p16.3 FGFR3 FGFR3</cell><cell>Hypochondroplasia AD 146000 4p16.3 FGFR3 FGFR3</cell><cell>Camptodactyly, tall stature, and AD 187600 4p16.3 FGFR3 FGFR3 Inactivating mutation</cell><cell>hearing loss syndrome (CATSHL)</cell><cell>Hypochondroplasia-like dysplasia(s) AD, SP Similar to hypochondroplasia</cell><cell>but unlinked to FGFR3,</cell><cell>probably heterogeneous;</cell><cell>uncertain diagnostic criteria</cell><cell>See also group 33 for craniosynostoses syndromes linked to FGFR3 mutations, as well as LADD syndrome in group 39 for another FGFR3-related phenotype</cell><cell>2. Type 2 collagen group and similar disorders</cell><cell>Achondrogenesis type 2 (ACG2; AD 200610 12q13.1</cell><cell>Langer-Saldino)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE I</head><label>I</label><figDesc></figDesc><table><row><cell>(Continued) Metaphyseal dysplasia with pancreatic insufficiency and cyclic neutropenia AR 260400 7q11 SBDS SBDS protein</cell><cell>Group/name of disorder Inheritance MIM No. Locus Gene Protein Notes (Shwachman-Bodian-Diamond</cell><cell>syndrome, SBDS) Spondylodysplastic Ehlers-Danlos AR 612350 11p11.2 SLC39A13 Zinc transporter ZIP13</cell><cell>Metaphyseal anadysplasia type 1 AD, AR 309645 11q22.2 MMP13 Matrix Includes SEMD Missouri type. syndrome</cell><cell>metalloproteinase 13 Both dominant and recessive SPONASTRIME dysplasia AR 271510</cell><cell>mutations described SEMD with joint laxity (SEMD-JL) AD 603546</cell><cell>Metaphyseal anadysplasia type 2 AR 20q13.12 MMP9 Matrix leptodactylic or Hall type</cell><cell>metalloproteinase 9 SEMD with joint laxity (SEMD-JL) AR 271640</cell><cell>Metaphyseal dysplasia, Spahr type AR 250400 Beighton type</cell><cell>Metaphyseal acroscyphodysplasia AR 250215 Platyspondyly (brachyolmia) with AR 601216</cell><cell>(various types) amelogenesis imperfecta</cell><cell>Genochondromatosis (type 1/type 2) AD/SP 137360 Late onset SED, autosomal recessive AR 609223</cell><cell>Metaphyseal chondromatosis AR/SP See type</cell><cell>with D-2-hydroxyglutaric aciduria 271550 Brachyolmia, Hobaek, and AR 271530, Nosologic relationship between</cell><cell>12. Spondylometaphyseal dysplasias (SMD) Toledo types 271630 the Toleado and Hobaek types</cell><cell>Spondyloenchondrodysplasia (SPENCD) AR 271550 19p13.2 ACP5 Tartrate-resistant Includes combined of brachyolmia and recessive</cell><cell>acid phosphatase (TRAP) immunodeficiency with late-onset SED are unclear,</cell><cell>autoimmunity and distinctive criteria lacking</cell><cell>spondylometaphyseal so far</cell><cell>dysplasia (MIM 607944)</cell><cell>Odontochondrodysplasia (ODCD) AR 184260</cell><cell>Spondylometaphyseal dysplasia, AD 184255 14. Severe spondylodysplastic dysplasias</cell><cell>Sutcliffe type or corner fractures type Achondrogenesis type 1A (ACG1A) AR 200600 14q32.12 TRIP11 Golgi-microtubule-associated</cell><cell>SMD with severe genu valgum AD 184253 Includes SMD Schmidt type and protein, 210-kDa; GMAP210</cell><cell>SMD Algerian type Schneckenbecken dysplasia AR 269250 1p31.3 SLC35D1 Solute carrier family 35 member</cell><cell>SMD with cone-rod dystrophy AR 608940 D1; UDP-glucuronic acid/</cell><cell>SMD with retinal degeneration, axial type AR 602271 UDP-N-acetylgalactosamine</cell><cell>Dysspondyloenchondromatosis SP dual transporter</cell><cell>Cheiro-spondyloenchondromatosis SP See also group 29 Spondylometaphyseal dysplasia, AR 250220</cell><cell>Sedaghatian type</cell><cell>Severe spondylometaphyseal dysplasia AR 7q11 SBDS SBDS gene, function still</cell><cell>Dyggve-Melchior-Clausen dysplasia AR 223800 18q12-21.1 DYM Dymeclin Includes Smith-McCort (SMD Sedaghatian-like) unclear</cell><cell>(DMC) dysplasia Opsismodysplasia AR 258480</cell><cell>Immuno-osseous dysplasia (Schimke) AR 242900 2q34-36 SMARCAL1 SWI/SNF-related regulator See also Thanatophoric dysplasia, types 1 and 2 (group 1); ACG2 and Torrance dysplasia (group 2); Fibrochondrogenesis (group 3); Achondrogenesis type 1B (ACG1B, group 4);</cell><cell>of chromatin subfamily A-like and Metatropic dysplasia (TRPV4 group)</cell><cell>protein 1 15. Acromelic dysplasias</cell><cell>SED, Wolcott-Rallison type AR 226980 2p12 EIF2AK3 Translation initiation factor Trichorhinophalangeal dysplasia AD 190350 8q24 TRPS1 Zinc finger</cell><cell>2-alpha kinase-3 types 1/3 transcription factor</cell><cell>SEMD, Matrilin type AR 608728 2p23-p24 MATN3 Matrilin 3 See also matrilin-related Trichorhinophalangeal dysplasia AD 150230 8q24 TRPS1 Microdeletion syndrome; see Zinc finger transcription</cell><cell>MED in group 8 type 2 (Langer-Giedion) and EXT1 also Multiple Cartilagineous factor and Exostosin 1</cell><cell>SEMD, short limb-abnormal AR 271665 1q23 DDR2 Discoidin domain receptor See also other dysplasias with Exostoses in group 28</cell><cell>calcification type family, member 2 stippling in group 20 Acrocapitofemoral dysplasia AR 607778 2q33-q35 IHH Indian hedgehog</cell><cell>SED tarda, X-linked (SED-XL) XLR 313400 Xp22 SEDL Sedlin Cranioectodermal dysplasia AR 218330 3q21 IFT122 Intraflagellar transport</cell><cell>Spondylo-megaepiphyseal-AR 613330 4p16.1 NKX3-2 NK3 Homeobox 2 (Levin-Sensenbrenner) type 1 122 (Chlamydomonas,</cell><cell>metaphyseal dysplasia (SMMD) homolog of)</cell><cell>Cranioectodermal dysplasia AR 613610 2p24.1 WDR35 WD repeat-containing</cell><cell>(Continued) (Levin-Sensenbrenner) type 2 protein 35</cell></row></table><note><p><s>See alsoSMD Kozlowski (group TRPV4)disorders in group 11 as well as SMD Sedaghatian type in group 12; there are many individual reports of SMD variants 13.</s><s>Spondylo-epi-(meta)-physeal dysplasias (SE(M)D) See also Brachyolmia (group 8), Opsismodysplasia (group 14), SEMDs (group 11), mucopolysaccharidosis type 4 (Morquio syndrome) and other conditions in group 26, as well as PPRD (SED with progressive arthropathy) in group 31</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE I</head><label>I</label><figDesc></figDesc><table><row><cell>(Continued) Geleophysic dysplasia AR 231050 9q34.2 ADAMTSL2 ADAMTS-like protein 2</cell><cell>Group/name of disorder Inheritance MIM No. Locus Gene Protein Notes Geleophysic dysplasia, other types AR Unlinked to ADAMTSL2 Acromicric dysplasia AD 102370 Includes acrolaryngeal Mesomelic dysplasia, Savarirayan type dysplasia, previously known (Triangular Tibia-Fibular Aplasia) as Fantasy Island dysplasia SP 605274 Possibly related to Nievergelt dysplasia. One case reported with 2q11.2 microdeletion of or Tattoo dysplasia unclear significance Acrodysostosis AD 101800 18. Bent bones dysplasias Angel-shaped phalango-epiphyseal AD 105835 Possibly related or allelic to Campomelic dysplasia (CD) dysplasia (ASPED) Brachydactyly type C AD 114290 17q24.3-25.1 SOX9 SRY-box 9 Includes acampomelic campomelic dysplasia (ACD) Saldino-Mainzer dysplasia AR 266920 as well as mild campomelic See also short rib dysplasias group dysplasia (MIM 602196) 16. Acromesomelic dysplasias St€ uve-Wiedemann dysplasia Acromesomelic dysplasia type AR 602875 9p13-12 NPR2 Natriuretic peptide AR 601559 5p13.1 LIFR Leukemia inhibitory factor receptor Maroteaux (AMDM) receptor 2 Includes formerly neonatal Schwartz-Jampel syndrome or SJS type 2 Grebe dysplasia AR 200700 20q11.2 GDF5 Growth and differentiation Includes acromesomelic Kyphomelic dysplasia, several forms factor 5 dysplasia Hunter-Thompson 211350 Probably heterogeneous Bent bones at birth can be seen in a variety of conditions, including osteogenesis imperfecta, Antley-Bixler syndrome, cartilage-hair hypoplasia, Cummings syndrome, type; see also hypophosphatasia, dyssegmental dysplasia, TD, ATD, and others Brachydactylies (group 34) 19. Slender bone dysplasia group Fibular hypoplasia and complex AR 228900 20q11.2 GDF5 Growth and differentiation See also Brachydactylies 3-M syndrome (3M1) brachydactyly (Du Pan) factor 5 (group 34) AR 273750 6p21.1 Cullin 7 Includes dolichospondylic dysplasia and Yakut short Acromesomelic dysplasia with genital AR 609441 4q23-24 BMPR1B Bone morphogenetic stature syndrome anomalies protein receptor 1B 3-M syndrome (3M2) Acromesomelic dysplasia, AD 112910 AR 612921 2q35 Obscurin-like 1 Kenny-Caffey dysplasia type 1 Osebold-Remondini type AR 244460 1q42-q43 Tubulin-specific chaperone E Kenny-Caffey dysplasia type 2 17. Mesomelic and rhizo-mesomelic dysplasias AD 127000 Microcephalic osteodysplastic Dyschondrosteosis (Leri-Weill) Pseudo-AD 127300 Xpter-p22.32 SHOX Short stature-homeobox gene Includes Reinhardt-Pfeiffer primordial dwarfism type 1/3 (MOPD1) dysplasia, MIM 191400 AR 210710 2q Includes Taybi-Linder cephaloskeletal dysplasia Microcephalic osteodysplastic Langer type (homozygous Pseudo-AR 249700 Xpter-p22.32 SHOX Short stature-homeobox gene primordial dwarfism type 2 (MOPD2; dyschondrosteosis) Majewski type) Omodysplasia AR 258315 13q31-q32 GPC6 Glypican 6 Existence of ''dominant AR 210720 21q Pericentrin 2 IMAGE syndrome (intrauterine growth omodysplasia'' (MIM retardation, metaphyseal dysplasia, 164745) remains to be adrenal hypoplasia, and genital confirmed anomalies) Robinow syndrome, recessive type AR 268310 9q22 ROR2 Receptor tyrosine kinase-like Includes previous XL/AD 300290 Possibly heterogeneous Osteocraniostenosis orphan receptor 2 costo-vertebral segmentation SP 602361 Occurrence in sibs reported, inheritance unclear defect with mesomelia Hallermann-Streiff syndrome (COVESDEM); see also AR 234100 Mutations in GJA1 reported in one case only brachydactyly type B See also Cerebro-arthro-digital dysplasia Robinow syndrome, dominant type AD 180700 20. Dysplasias with multiple joint dislocations Mesomelic dysplasia, Korean type AD 2q24-32 Duplication in HOXD gene cluster Desbuquois dysplasia (with Mesomelic dysplasia, Kantaputra type AD 156232 2q24-32 Duplications in HOXD gene cluster accessory ossification center in digit 2) Mesomelic dysplasia, Nievergelt type AD 163400 AR 251450 17q25.3 Desbuquois dysplasia with short Mesomelic dysplasia, AR 249710 metacarpals and elongated phalanges Kozlowski-Reardon type (Kim type) Mesomelic dysplasia with acral AD 600383 8q13 SULF1 and Heparan sulfate 6-O-Microdeletion syndrome AR 251450 17q25.3 CUL7 OBSL1 TBCE PCNT2 CANT1 CANT1</cell><cell>synostoses (Verloes-David-Pfeiffer type) SLCO5A1 endosulfatase 1 and solute involving two adjacent genes</cell><cell>carrier organic anion trans-</cell><cell>porter</cell><cell>family member 5A1</cell><cell>(Continued)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE I</head><label>I</label><figDesc></figDesc><table><row><cell>Desbuquois dysplasia (other variants AR Probably genetically</cell><cell>(Continued) with or without accessory heterogeneous</cell><cell>Group/name of disorder Inheritance MIM No. Locus Gene Protein Notes ossification center) Pseudodiastrophic dysplasia AR 264180 Osteopetrosis, infantile form, with See also SED with congenital dislocations, CHST3 type (group 4); Atelosteogenesis type 3 and Larsen syndrome (group 6); SEMDs with joint laxity (group 11) nervous system involvement (OPTB5) 21. Chondrodysplasia punctata (CDP) group AR 259720 6q21 OSTM1 Gray lethal/osteopetrosis associated transmembrane protein CDP, X-linked dominant, XLD 302960 Xp11 EBP Emopamil-binding protein Osteopetrosis, intermediate form, Conradi-H€ unermann type (CDPX2) osteoclast-poor (OPTB2) CDP, X-linked recessive, XLR 302950 Xp22.3 ARSE Arylsulfatase E AR 259710 13q14.11 RANKL (TNFSF11) Receptor activator of NF-kappa-B ligand (tumor necrosis factor li gand superfamily, member 11) brachytelephalangic type (CDPX1) Osteopetrosis, infantile form, Congenital hemidysplasia, XLD 308050 Xp11 NSDHL NAD(P)H steroid osteoclast-poor with immunoglobulin ichthyosis, limb defects (CHILD) dehydrogenase-like protein deficiency (OPTB7) Congenital hemidysplasia, ichthyosis, XLD 308050 Xq28 EBP Emopamil-binding protein AR 612302 18q21.33 RANK (TNFRSF11A) Receptor activator of NF-kappa-B Osteopetrosis, intermediate form limb defects (CHILD) (OPTB6) Greenberg dysplasia AR 215140 1q42.1 LBR Lamin B receptor, Includes hydrops-ectopic AR 611497 17q21.3 PLEKHM1 Pleckstrin homology domain-containing protein, family M, member 1 3-beta-hydroxysterol delta calcification-moth-eaten Osteopetrosis, intermediate form (14)-reductase appearance dysplasia (HEM) (OPTA2) and dappled diaphyseal AR 259710 16p13 CLCN7 Chloride channel pump Osteopetrosis with renal tubular dysplasia acidosis (OPTB3) Rhizomelic CDP type 1 AR 215100 6q22-24 PEX7 Peroxisomal PTS2 receptor AR 259730 8q22 CA2 Carbonic anhydrase 2 Osteopetrosis, late-onset form type 1 Rhizomelic CDP type 2 AR 222765 1q42 DHPAT Dihydroxyacetonephosphate (OPTA1) acyltransferase (DHAPAT) AD 607634 11q13.4 LRP5 Low density lipoprotein receptor-related protein 5 Osteopetrosis, late-onset form type 2 Rhizomelic CDP type 3 AR 600121 2q31 AGPS Alkylglycerone-phosphate (OPTA2) synthase (AGPS) AD 166600 16p13 CLCN7 Chloride channel 7 Osteopetrosis with ectodermal CDP tibial-metacarpal type AD/AR 118651 Nosologic status uncertain dysplasia and immune defect (OLEDAID) Astley-Kendall dysplasia AR? Relationship to OI and to XL 300301 Xq28 IKBKG (NEMO) Inhibitor of kappa light polypeptide gene enhancer, kinase of Greenberg dysplasia unclear Osteopetrosis, moderate form with AR 612840 11q12 FERMT3 Fermitin 3 (Kindlin 3) Note that stippling can occur in several syndromes such as Zellweger, Smith-Lemli-Opitz and others. See also desmosterolosis as well as SEMD short limb-abnormal calcification defective leucocyte adhesion (LAD3) type in group 11 (KIND3) Osteopetrosis, moderate form with 22. Neonatal osteosclerotic dysplasias defective leucocyte adhesion Blomstrand dysplasia AR 215045 3p22-21.1 PTHR1 PTH/PTHrP receptor 1 AR 612840 11q13 RASGRP2 (CalDAG-GEF1) Ras guanyl nucleotide-releasing protein 2 Pyknodysostosis AR 265800 1q21 CTSK Cathepsin K Caused by recessive inactivating mutations; see Osteopoikilosis AD 155950 12q14 LEMD3 LEM domain-containing 3 also Eiken dysplasia and See also familial expansile osteolysis in Osteolysis group (group 28) Includes Worth type osteosclerosis (MIM 144750) Includes Buschke-Ollendorff syndrome (MIM 166700) Jansen dysplasia Melorheostosis with osteopoikilosis Desmosterolosis AR 602398 1p33-31.1 DHCR24 3-beta-hydroxysterol AD 155950 12q14 LEMD3 LEM domain-containing 3 See also other sterol-Includes mixed sclerosing bone dysplasia delta-24-reductase Osteopathia striata with cranial XLD 300373 Xq11.1 WTX FAM123B metabolism related conditions sclerosis (OSCS) Caffey disease (including infantile and AD 114000 17q21-22 COL1A1 Collagen 1, alpha-1 chain Melorheostosis attenuated forms) SP See also osteogenesis imperfecta related to collagen No germ line LEMD3 mutations identified so far 1 genes (group 24) Dysosteosclerosis Caffey disease (severe variants with AR 114000 AR 224300 Possibly related to ''osteosclerotic metaphyseal prenatal onset) dysplasia'' Raine dysplasia (lethal and AR 259775 7p22 FAM20C Osteomesopyknosis non-lethal forms) AD 166450 Osteopetrosis with infantile See also Astley-Kendall dysplasia and CDPs in group 21 neuroaxonal dysplasia 23. Increased bone density group (without modification of bone shape) AR? 600329 Includes lethal and non-lethal cases Same as osteopetrosis with nervous system involvement (see above)? Osteopetrosis, severe neonatal or AR 259700 11q13 TCIRG1 Subunit of ATPase proton</cell><cell>infantile forms (OPTB1) pump</cell><cell>Osteopetrosis, severe neonatal or AR 611490 16p13 CLCN7 Chloride channel 7</cell><cell>infantile forms (OPTB4)</cell><cell>(Continued)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>TABLE I</head><label>I</label><figDesc></figDesc><table><row><cell cols="3">954</cell><cell>AMERICAN JOURNAL OF MEDICAL GENETICS PART A</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Notes</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Protein</cell></row><row><cell>24. Increased bone density group with metaphyseal and/or diaphyseal involvement</cell><cell>Craniometaphyseal dysplasia, AD 123000 5p15.2-14.2</cell><cell>(Continued) autosomal dominant type</cell><cell>Gene Group/name of disorder Inheritance MIM No. Locus</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>TABLE I</head><label>I</label><figDesc></figDesc><table><row><cell>See also Craniosynostosis</cell><cell>Notes syndromes in group 30 Notes</cell><cell></cell><cell></cell><cell cols="2">PTHR1 and PTPN11 mutations</cell><cell cols="2">found in a few cases only, role</cell><cell cols="2">still unclear</cell><cell cols="2">PTPN11 mutations found in a</cell><cell cols="2">few cases only, role unclear Includes Juvenile hyaline</cell><cell>fibromatosis (JHF, 228600)</cell><cell cols="2">Some cases reported with and Puretic syndrome</cell><cell cols="2">NSD1 mutations</cell><cell cols="2">(see Sotos syndrome)</cell><cell>Some cases may have</cell><cell cols="2">NFIX mutations (see</cell><cell cols="2">Marshall-Smith syndrome)</cell><cell>Some clinical overlap with</cell><cell>Sotos syndrome (see above) See also Frontonasal Some Proteus-like cases have dysplasia type 1 (group 34) mutations in the PTEN gene</cell><cell>Most have FGFR1 P252R</cell><cell>mutation (phenotype</cell><cell>Overgrowth probably caused by generally milder than FGFR2-related Pfeiffer) overexpression of NPPC Includes Jackson-Weiss Nosologic status unclear but syndrome (MIM 123150) and conspicuous skeletal Antley-Bixler variants caused phenotype(s) by FGFR2 mutations (see</cell><cell>below)</cell><cell>(Continued)</cell></row><row><cell>Fibroblast growth factor</cell><cell>Protein receptor 1 Activin A (BMP type 1) receptor Interleukin 1 receptor Protein</cell><cell>Neurofibromin antagonist</cell><cell>Lipin 2</cell><cell>UDP-N-acetyl-alpha-</cell><cell cols="2">D-galactosamine:polypeptide N</cell><cell cols="2">-</cell><cell cols="2">acetylgalactosaminyltransfer-</cell><cell cols="2">ase 3</cell><cell>Anthrax toxin receptor 2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Runt related transcription</cell><cell cols="2">Nuclear receptor-binding factor 2</cell><cell cols="2">su-var, enhancer of zeste,</cell><cell cols="2">and trithorax domain</cell><cell>protein 1</cell><cell>Nuclear factor I/X</cell><cell>Aristaless-like 4</cell><cell>Fibrillin 1 Muscle segment homeobox 2 Fibrillin 2</cell><cell>TGFbeta receptor</cell><cell>subunit 1 Fibroblast growth factor TGFbeta receptor receptor 1 subunit 2</cell><cell>Natriuretic peptide</cell><cell>precursor C Fibroblast growth factor</cell><cell>receptor 2</cell><cell>WNT1-inducible signaling Fibroblast growth factor receptor 2 pathway protein 3 Fibroblast growth factor</cell><cell>Cryopyrin receptor 2 Fibroblast growth factor</cell><cell>receptor 2</cell></row><row><cell>(Continued) Osteoglophonic dysplasia AD 166250 8p11 FGFR1 Crouzon-like craniosynostosis with AD 612247 TABLE I(Continued) 4p16.3</cell><cell cols="6">Group/name of disorder Inheritance MIM No. Locus Gene Fibrodysplasia ossificans progressiva AD, SP 135100 2q23-24 ACVR1 Sterile multifocal osteomyelitis, (FOP) periostitis, and pustulosis Neurofibromatosis type 1 (NF1) AD 162200 17q11.2 NF1 (CINCA/NOMID-like) Carpotarsal osteochondromatosis AD 127820 AR 147679 2q14.2 IL1RN Chronic recurrent multifocal Cherubism with gingival fibromatosis AR 266270 osteomyelitis with congenital (Ramon syndrome) dyserythropoietic anemia (CRMO with Dysplasia epiphysealis hemimelica SP 127800 CDA; Majeed syndrome) (Trevor) AR 609628 18p11.3 LPIN2 Hyperostosis/hyperphosphatemia Enchondromatosis (Ollier) SP 166000 syndrome AR 610233 2q24-q31 GALNT3 Group/name of disorder Inheritance MIM No. acanthosis nigricans (Crouzonodermoskeletal syndrome) Gene Locus</cell><cell></cell><cell></cell><cell></cell><cell cols="2">Enchondromatosis with hemangiomata SP 166000</cell><cell cols="4">(Maffucci) Infantile systemic hyalinosis/Juvenile See also Proteus syndrome in group 30 hyaline fibromatosis (ISH/JHF) 30. Overgrowth syndromes with skeletal involvement AR 236490 4q21 ANTXR2</cell><cell cols="2">Weaver syndrome SP/AD 277590 32. Cleidocranial dysplasia and isolated cranial ossification defects group</cell><cell cols="2">Cleidocranial dysplasia AD 119600 6p21 RUNX2</cell><cell></cell><cell cols="2">Sotos syndrome AD 117550 5q35 NSD1 CDAGS syndrome (craniosynostosis, AR 603116 22q12-q13</cell><cell cols="2">delayed fontanel closure, parietal</cell><cell cols="2">foramina, imperforate a.u., genital</cell><cell>Marshall-Smith syndrome SP 602535 19p13.3 NFIX anomalies, skin eruption) Yunis-Varon dysplasia AR 216340</cell><cell>Proteus syndrome SP 176920 Parietal foramina (isolated) AD 168500 11q11.2 ALX4</cell><cell>Marfan syndrome AD 154700 15q21.1 FBN1 Parietal foramina (isolated) AD 168500 5q34-35 MSX2</cell><cell>Congenital contractural arachnodactyly AD 121050 5q23.3 FBN2 See also pycnodysostosis, wrinkly skin syndrome, and several others Loeys-Dietz syndrome types AD 609192, 9q22 TGFBR1 33. Craniosynostosis syndromes 1A and 2A 610168, Pfeiffer syndrome (FGFR1-related) Loeys-Dietz syndrome types AD 608967, 3p22 TGFBR2 AD 101600 8p12 FGFR1</cell><cell>1B and 2B 610380</cell><cell>Overgrowth syndrome with 2q37 SP -2q37 NPPC</cell><cell>translocations Pfeiffer syndrome (FGFR2-related) Overgrowth syndrome with skeletal SP? AD 101600 10q26.12 FGFR2</cell><cell>dysplasia (Nishimura-Schmidt,</cell><cell>endochondral gigantism)</cell><cell>See also Shprintzen-Goldberg syndrome in Craniosynostosis group</cell><cell>31. Genetic inflammatory/rheumatoid-like osteoarthropathies Apert syndrome Progressive pseudorheumatoid AR 208230 6q22-23 WISP3 AD 101200 10q26.12 FGFR2</cell><cell>dysplasia (PPRD; SED with progressive Craniosynostosis with cutis gyrata arthropathy) (Beare-Stevenson) Chronic infantile neurologic cutaneous AD 607115 1q44 CIAS1 AD 123790 Crouzon syndrome articular syndrome (CINCA)/neonatal AD 123500 10q26.12 FGFR2 10q26.12 FGFR2</cell><cell>onset multisystem inflammatory</cell><cell>disease (NOMID)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>TABLE I</head><label>I</label><figDesc></figDesc><table><row><cell cols="2">each gene separately, advocated by some scholars, is more confusing</cell></row><row><cell cols="2">than helpful in clinical practice.</cell></row><row><cell></cell><cell>Group 26 has seen the identification of several novel molecular</cell></row><row><cell cols="2">mechanisms leading to hypophosphatemic rickets.</cell></row><row><cell></cell><cell>Notes</cell></row><row><cell></cell><cell>Protein</cell></row><row><cell>(Continued)</cell><cell>Gene</cell></row><row><cell></cell><cell>Locus</cell></row><row><cell></cell><cell>Inheritance MIM No.</cell></row><row><cell></cell><cell>Group/name of disorder</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>M.L.W. is an Investigator with the Howard Hughes Medical Institute, and A.S.F. is supported by the Leenaards Foundation (Lausanne, Switzerland) and by the Facult e de Biologie et Medicine of the Lausanne University.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">International nomenclature of constitutional diseases of bones</title>
	</analytic>
	<monogr>
		<title level="j">Ann Radiol (Paris)</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="455" to="464" />
			<date type="published" when="1970">1970</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A nomenclature for constitutional (intrinsic) diseases of bones</title>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="177" to="179" />
			<date type="published" when="1971">1971a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">International nomenclature of constitutional bone diseases. Constitutional bone diseases without known pathogenesis</title>
	</analytic>
	<monogr>
		<title level="j">Arch Fr Pediatr</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="553" to="557" />
			<date type="published" when="1971">1971b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Nomenclature for constitutional (intrinsic) diseases of bones</title>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="431" to="434" />
			<date type="published" when="1971">1971c</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Nomenclature for the constitutional (intrinsic) diseases of bone</title>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="699" to="702" />
			<date type="published" when="1971">1971d</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">International nomenclature of constitutional diseases of bone. Revision-May</title>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="614" to="616" />
			<date type="published" when="1977">1978. 1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">International nomenclature of constitutional diseases of bone: Revision-May 1977</title>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="21" to="26" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">International nomenclature of constitutional diseases of bone. Revision</title>
	</analytic>
	<monogr>
		<title level="j">Ann Radiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="457" to="462" />
			<date type="published" when="1983-05">1983. May. 1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">International nomenclature and classification of the osteochondrodysplasias</title>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="376" to="382" />
			<date type="published" when="1997">1998. 1997</date>
		</imprint>
	</monogr>
	<note>International working group on constitutional diseases of bone</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">International nosology and classification of constitutional disorders of bone (2001)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Hall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="65" to="77" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">International nomenclature and classification of the osteochondrodysplasias</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Lachman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Radiol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="737" to="744" />
			<date type="published" when="1997">1998. 1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">A nomenclature for constitutional disorders of bone</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Mckusick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Scott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Joint Surg Am</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="978" to="986" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Newly recognized syndrome of metaphyseal undermodeling, spondylar dysplasia, and overgrowth: Report of two adolescents and a child</title>
		<author>
			<persName><forename type="first">G</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kinoshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kurosawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet Part A</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="204" to="208" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">International nomenclature of constitutional diseases of bone with bibliography</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Rimoin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Birth Defects Orig Artic Ser</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">30</biblScope>
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Endochondral gigantism: A newly recognized skeletal dysplasia with preand postnatal overgrowth and endocrine abnormalities</title>
		<author>
			<persName><forename type="first">H</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Enders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kiess</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet Part A</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1868" to="1875" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Classification of osteogenesis imperfect</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Sillence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Rimoin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="1041" to="1042" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Sillence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Rimoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Danks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Birth Defects Orig Artic Ser</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="113" to="129" />
			<date type="published" when="1979">1979a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Genetic heterogeneity in osteogenesis imperfecta</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Sillence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Senn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Danks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="101" to="116" />
			<date type="published" when="1979">1979b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">International classification of osteochondrodysplasias. The international working group on constitutional diseases of bone</title>
		<author>
			<persName><forename type="first">J</forename><surname>Spranger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pediatr</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="407" to="415" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Neurofibromatosis type 1 is a genetic skeletal disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Viskochil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Carey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet Part A</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="2082" to="2083" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>author reply 2084</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Nosology and classification of genetic skeletal disorders: 2006 revision</title>
		<author>
			<persName><forename type="first">A</forename><surname>Superti-Furga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Unger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet Part A</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Nosology and Classification of Genetic Skeletal Disorders: 2010 Revision</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Warman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V;</forename><surname>Cormier-Daire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C;</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Krakow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R;</forename><surname>;Lachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M;</forename><surname>Lemerrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mortier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S;</forename><surname>;Mundlos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName><surname>;Rimoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S;</forename><surname>Dl;Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R;</forename><surname>Savarirayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D;</forename><surname>Sillence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J;</forename><surname>Spranger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S;</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zabel</surname></persName>
		</author>
		<author>
			<persName><surname>Superti-Furga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Title ; Warman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cormier-Daire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Krakow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lemerrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mortier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mundlos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Rimoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Savarirayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sillence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Spranger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Superti-Furga</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajmg.a.33909</idno>
		<ptr target="http://hdl.handle.net/11343/264780" />
	</analytic>
	<monogr>
		<title level="j">AMERICAN JOURNAL OF MEDICAL GENETICS PART A</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="943" to="968" />
			<date type="published" when="2010">2010 Revision Date: 2011-05-01. 2011</date>
		</imprint>
		<respStmt>
			<orgName>Minerva Access is the Institutional Repository of The University of Melbourne Author/s</orgName>
		</respStmt>
	</monogr>
	<note>Nosology and Classification of Genetic Skeletal Disorders</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
